ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $116,000 | -87.9% | 49,100 | -76.0% | 0.00% | -88.9% |
| Q4 2019 | $962,000 | +187.2% | 204,700 | +85.4% | 0.01% | +80.0% |
| Q1 2019 | $335,000 | -60.4% | 110,408 | -64.5% | 0.01% | -66.7% |
| Q4 2018 | $847,000 | +810.8% | 311,400 | +974.9% | 0.02% | +650.0% |
| Q2 2017 | $93,000 | -76.3% | 28,970 | -79.1% | 0.00% | -75.0% |
| Q1 2017 | $393,000 | +495.5% | 138,512 | +83.9% | 0.01% | +700.0% |
| Q1 2016 | $66,000 | – | 75,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |